Abstract
The pituitary gland is a potential site for a range of pathologies, for which treatment can involve resection and/or ionizing radiation. Modern stereotactic radiosurgery (SRS) involves highly conformal radiation, allowing for the delivery of high doses to the tumor while simultaneously sparing nearby healthy structures. SRS has become a standard treatment option for residual or recurrent pituitary adenomas. It has been used for both functioning and nonfunctioning pituitary adenomas, with reported local tumor control over 90% and moderate rates of endocrine remission in functioning adenomas. We aim to briefly review the existing indictions and supporting literature for the use of SRS for refractory adenomas.
Similar content being viewed by others
Data availability
Data are available from the corresponding author upon reasonable request.
References
Kotecha R, Sahgal A, Rubens M, De Salles A, Fariselli L, Pollock BE et al (2020) Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion. Neurooncology 22(3):318–332
Cohen-Inbar O, Xu Z, Lee C-c, Wu C-C, Chytka T, Silva D et al (2017) Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study. J Neurooncol 135(1):67–74
Losa M, Spatola G, Albano L, Gandolfi A, Del Vecchio A, Bolognesi A et al (2017) Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas. Endocrine 56(3):595–602
Park K-J, Kano H, Parry PV, Niranjan A, Flickinger JC, Lunsford LD et al (2011) Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery 69(6):1188–1199
Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL et al (2013) Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg 119(2):446–456
Dutta SW, Kowalchuk RO, Trifiletti DM, Peach MS, Sheehan JP, Larner JM et al (2018) Stereotactic shifts during frame-based image-guided stereotactic radiosurgery: clinical measurements. Int J Radiat Oncol Biol Phys 102(4):895–902
Kowalchuk RO, Niranjan A, Lee C-C, Yang H-C, Liscak R, Guseynova K et al (2022) Reirradiation with Stereotactic Radiosurgery after local or marginal recurrence of Brain Metastases from previous Radiosurgery. Int J Radiat Oncol Biol Phys 112(3):726–734
Kowalchuk RO, Shepard MJ, Sheehan K, Sheehan D, Faramand A, Niranjan A et al (2021) Treatment of WHO Grade 2 Meningiomas with Stereotactic Radiosurgery: identification of an Optimal Group for SRS using RPA. Int J Radiation Oncology* Biology* Phys 110(3):804–814
Kowalchuk RO, Niranjan A, Hess J, Antonios JP, Zhang MY, Braunstein S et al (2022) Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer.Journal of Neurosurgery. :1–7
Jette D, Chen W (2011) Creating a spread-out Bragg peak in proton beams. Phys Med Biol 56(11):N131
Loeffler JS, Shih HA (2011) Radiation Therapy in the management of Pituitary Adenomas. J Clin Endocrinol Metabolism 96(7):1992–2003
Kowalchuk RO, Trifiletti DM, Brown PD, Sheehan JP (2022) Radiotherapy in the Management of Pituitary Adenomas. The Pituitary. :753 – 64
Sheehan JP, Xu Z, Salvetti DJ, Schmitt PJ, Vance ML (2013) Results of Gamma Knife surgery for Cushing’s disease. J Neurosurg 119(6):1486–1492
Pollock BE, Jacob JT, Brown PD, Nippoldt TB (2007) Radiosurgery of growth hormone–producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106(5):833–838
Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW (2000) Radiosurgery for growth hormone—producing pituitary adenomas. J Neurosurg 93(supplement3):6–9
Ding D, Mehta GU, Patibandla MR, Lee C-C, Liscak R, Kano H et al (2019) Stereotactic radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study. Neurosurgery 84(3):717–725
Pan L, Zhang N, Wang EM, Wang BJ, Dai JZ, Cai PW (2000) Gamma knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg 93(supplement3):10–13
Verma J, McCutcheon IE, Waguespack SG, Mahajan A (2014) Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas. Pituitary 17:539–545
Xu Z, Ellis S, Lee C-C, Starke RM, Schlesinger D, Vance ML et al (2014) Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study. Int J Radiat Oncol Biol Phys 15:903–910
Dumot C, Schlesinger D, Mantziaris G, Dayawansa S, Xu Z, Sheehan JP (2022) Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery.Pituitary.
Minniti G, Paolini S, Rea MLJ, Isidori A, Scaringi C, Russo I et al (2020) Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas. J Neurooncol 149(1):123–130
Marek J, Jezkova J, Hana V, Krsek M, Bandúrová Lu, Pecen L et al (2011) Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife? Eur J Endocrinol 164(2):169
Patel TR, Chiang VLS (2014) Secondary neoplasms after stereotactic radiosurgery. World Neurosurg 81:594–599
Wolf A, Naylor K, Tam M, Habibi A, Novotny J, Liscak R et al (2019) Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study. Lancet Oncol 20:159–164
Funding
No funding was required for this study.
Author information
Authors and Affiliations
Contributions
ROK drafted the initial version of the manuscript, which was then edited by ROK and JPS. All authors subsequently reviewed and edited the document. All authors have read the final version of the manuscript and are in agreement with the submission.
Corresponding author
Ethics declarations
Ethical approval
The manuscript was written using best ethical and research practices.
Competing interests
Dr. Kowalchuk reports that his spouse is employed by GE Healthcare. There are no other relevant conflicts of interest to disclose. Dr. Brown is a contributor to UpToDate (honorarium) outside submitted work.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kowalchuk, R.O., Trifiletti, D.M., Brown, P.D. et al. Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas. Pituitary 26, 298–302 (2023). https://doi.org/10.1007/s11102-023-01300-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-023-01300-z